BRIEF-Vivus up in premarket after qsymia study results

NEW YORK Fri Feb 1, 2013 7:59am EST

NEW YORK Feb 1 (Reuters) - Vivus Inc : * Up 4.1 percent to $12.60 in premarket after qsymia study results

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.